🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison photos, administration instructions and assertions of rapid British shipping. Sellers promote the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users administering substances of unknown origin.

Some experts said the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.

Platform Response and Content Elimination

According to TikTok, the platform has removed problematic content and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the service secure and investing in strengthening compliance measures.

Online Trading Operations

Investigations also discovered groups with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.

After minutes of entering one group, a seller shared contact information, where the majority of purchases take place. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.

Product Information and Costs

Inside these communities, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly serious medical dangers”.